The αiIb p.Leu841Met (Cab3a+) polymorphism results in a new human platelet alloantigen involved in neonatal alloimmune thrombocytopenia

Transfusion

Volumn 53, Issue 3, 2013, Pages 554-563

  Jallu, Vincent ^a   Bertrand, Gerald ^a   Bianchi, Frederic ^a   Chenet, Christophe ^a   Poulain, Pierre ^a   Kaplan, Cecile ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN;

ALLELE; ARTICLE; BLEEDING; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; POLYMERASE CHAIN REACTION; PROTEIN POLYMORPHISM; THROMBOCYTE; THROMBOCYTOPENIA;

ADULT; AMINO ACID SUBSTITUTION; ANTIGENS, HUMAN PLATELET; FEMALE; FETAL DEATH; HEK293 CELLS; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LEUCINE; MALE; METHIONINE; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET MEMBRANE GLYCOPROTEIN IIB; PREGNANCY; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84874946149     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03762.x     Document Type: Article

References (37)

1. Harrington WJ, Sprague CC, Minnich V, Moore CV, Aulvin RC, Dubach R,. Immunologic mechanisms in neonatal and thrombocytopenic purpura. Ann Intern Med 1953; 38: 433-69.
2. Dreyfus M, Kaplan C, Verdy E, Schlegel N, Durand-Zaleski I, Tchernia G,; the "Immune Thrombocytopenia" Working Group. Frequency of immune thrombocytopenia in newborns: a prospective study. Blood 1997; 89: 4402-6.
3. Farrell DH, Thiagarajan P, Chung DW, Davie EW,. Role of fibrinogen α and β chain sites in platelet aggregation. Proc Natl Acad Sci U S A 1992; 89: 10729-32.
4. Liu Q, Rooney MM, Kasirer-Friede A, Brown E, Lord ST, Frojmovic MM,. Role of the γ chain Ala-Gly-Asp-Val and Aα chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads. Biochim Biophys Acta 1998; 1385: 33-42.
5. Lyman S, Aster RH, Visentin GP, Newman PJ,. Polymorphism of human platelet membrane glycoprotein IIb associated with the Baka/Bakb alloantigen system. Blood 1990; 75: 2343-8.
6. a, a new low-frequency platelet-specific antigen localized on glycoprotein IIb, is associated with neonatal alloimmune thrombocytopenia. Blood 1995; 86: 1019-26.
7. Peterson JA, Gitter ML, Kanack A, Curtis B, McFarland J, Bougie D, Aster R,. New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia. Transfusion 2010; 50: 324-33.
8. Jallu V, Dusseaux M, Kaplan C,. A new Ser472Asn (Cab2(a+)) polymorphism localized within the alphaIIb "thigh" domain is involved in neonatal thrombocytopenia. Transfusion 2011; 51: 393-400.
9. Halle L, Jallu V, Mulen-Imandy G, Bigot A, M'Bayo K, Anani LY, Kaplan C,. New mutations on platelet GPIIb in Sub-Saharan African populations revealed by genotyping discrepancies. Transfusion 2008; 48: 1415-22.
10. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C,. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987; 70: 1722-6.
11. Jallu V, Dusseaux M, Panzer S, Torchet MF, Hezard N, Goudemand J, de Brevern AG, Kaplan C,. AlphaIIbbeta3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression, and structure-function. Hum Mutat 2010; 31: 237-46.
12. Jallu V, Meunier M, Brement M, Kaplan C,. A new platelet polymorphism Duv(a+), localized within the RGD binding domain of glycoprotein IIIa, is associated with neonatal thrombocytopenia. Blood 2002; 99: 4449-56.
13. DeLano WL,. The PyMOL molecular graphics system, version 1.5.0.4. Camberley, UK: Schrödinger, LLC; 2002.
14. Hess B, Kutzner C, van der Spoel D, Lindahl E,. GROMACS 4: algorithms for highly effcient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 2008; 4: 435-47.
15. Jorgensen WL, Maxwell DS, Tirado-Rives J,. Development and testing of the OPLS All-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 1996; 118: 11225-36.
16. Joseph AP, Agarwal G, Mahajan S, Gelly JC, Swapna LS, Offmann B, Cadet F, Bornot A, Tyagi M, Valadie H, Schneider B, Etchebest C, Srinivasan N, De Brevern AG,. A short survey on protein blocks. Biophys Rev 2010; 2: 137-47.
17. de Brevern AG, Etchebest C, Hazout S,. Bayesian probabilistic approach for predicting backbone structures in terms of protein blocks. Proteins 2000; 41: 271-87.
18. Tyagi M, Bornot A, Offmann B, de Brevern AG,. Protein short loop prediction in terms of a structural alphabet. Comput Biol Chem 2009; 33: 329-33.
19. Crooks GE, Hon G, Chandonia JM, Brenner SE,. WebLogo: a sequence logo generator. Genome Res 2004; 14: 1188-90.
20. Zhu J, Luo BH, Xiao T, Zhang C, Nishida N, Springer TA,. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell 2008; 32: 849-61.
21. Tokuhira M, Handa M, Kamata T, Oda A, Katayama M, Tomiyama Y, Murata M, Kawai Y, Watanabe K, Ikeda Y,. A novel regulatory epitope defined by a murine monoclonal antibody to the platelet GPIIb-IIIa complex (alpha IIb beta 3 integrin). Thromb Haemost 1996; 76: 1038-46.
22. Jones D, Fritschy J, Garson J, Nokes TJ, Kemshead JT, Hardisty RM,. A monoclonal antibody binding to human medulloblastoma cells and to the platelet glycoprotein IIB-IIIA complex. Br J Haematol 1984; 57: 621-31.
23. Pidard D, Montgomery RR, Bennett JS, Kunicki TJ,. Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. J Biol Chem 1983; 258: 12582-6.
24. Vahdati-Ben AS, Laham N, Schechter C, Yewdell JW, Coligan JE, Ehrlich R,. A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules. Blood 2003; 101: 2858-64.
25. Barba P, Pallares P, Nogues N, Canals C, Gracia M, Vinyets I, Muniz-Diaz E,. Post-transfusion purpura caused by anti-HPA-3a antibodies that are only detectable using whole platelets in the platelet immunofluorescence test. Transfus Med 2010; 20: 200-2.
26. Harrison CR, Curtis BR, McFarland JG, Huff RW, Aster RH,. Severe neonatal alloimmune thrombocytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in whole platelet assays. Transfusion 2003; 43: 1398-402.
27. Kataoka S, Kobayashi H, Chiba K, Nakamura M, Shinada S, Morita S, Lin M, Shibata Y,. Neonatal alloimmune thrombocytopenia due to an antibody against a labile component of human platelet antigen-3b (Bakb). Transfus. Medicine 2004; 14: 419-23.
28. Lin M, Shieh SH, Liang DC, Yang TF, Shibata Y,. Neonatal alloimmune thrombocytopenia in Taiwan due to an antibody against a labile component of HPA-3a (Baka). Vox Sang 1995; 69: 336-40.
29. a) is an important cause of neonatal alloimmune thrombocytopenia. Transfusion 2005; 45: 1487-95.
30. a) feto-maternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy, report on 8 families. Transfusion 2005; 45: 1799-803.
31. Socher I, Zwingel C, Santoso S, Kroll H,. Heterogeneity of HPA-3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes. Transfusion 2008; 48: 463-72.
32. a (HPA-3a) to the C-terminus of platelet glycoprotein IIb heavy chain and contribution of O-linked carbohydrates. Thromb Haemost 1993; 69: 485-9.
33. Schallmoser K, Kutschera J, Macher S, Ulrich S, Eichler P, Panzer S, Lanzer G,. Delayed detectability of anti-HPA-3a by the MAIPA assay in a severe neonatal alloimmune thrombocytopenia, but successful transfusion of incompatible donor platelets: a case report. Vox Sang 2006; 91: 181-3.
34. Glade-Bender J, McFarland JG, Kaplan C, Porcelijn L, Bussel JB,. Anti-HPA-3a induces severe neonatal alloimmune thrombocytopenia. J Pediatr 2001; 138: 862-7.
35. de Leon EJ, Yuan FF, Pearson H, Marquis CP, Mahler SM,. Evidence of heterogeneity in the antibody response against the platelet antigen 3a; recognition of an 11-mer peptide carrying the HPA-3a polymorphic determinant. Vox Sang 2009; 96: 252-5.
36. Kyte J, Doolittle RF,. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982; 157: 105-32.
37. Etchebest C, Benros C, Bornot A, Camproux AC, de Brevern AG,. A reduced amino acid alphabet for understanding and designing protein adaptation to mutation. Eur Biophys J 2007; 36: 1059-69.